Score history

VERATIS score history

Every recorded change to VERATIS’s overall score since October 14, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.

Score today
7.21/10

Score today

Score changes
12

Score changes

Audit entries
13

Audit entries

Score over time

6.57.07.58.0Nov 20267.21
Overall score, October 14, 2026 to November 6, 2026. Each dot is a recorded score; the filled dot is today’s.

Every entry newest first

  1. Raised from7.19to7.21(+0.02)

    Market medians updated after Pacific Edge Labs was added pricing 6.0 to 6.1.

  2. Lowered from7.21to7.19(-0.02)

    Market medians updated after Snowman Research was added pricing 6.1 to 6.0.

  3. Raised from7.19to7.21(+0.02)

    Market medians updated after Stack Research was added pricing 6.0 to 6.1.

  4. Lowered from7.21to7.19(-0.02)

    Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (StudzPeptides) moved the market median for the same products: pricing 6.1 to 6.0.

  5. Lowered from7.24to7.21(-0.03)

    Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 6.3 to 6.1.

  6. Raised from7.21to7.24(+0.03)

    Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 6.1 to 6.3.

  7. Lowered from7.22to7.21(-0.01)

    Pricing recomputed on 23 October 2026 under the revised rule E1 (standing offers), which prices a size at the lowest total a buyer can pay without a code under standing prices, so a standing offer that includes a second vial at no extra cost now counts at all the milligrams received, in the vendor's own price and in the market medians for the same products: pricing 6.2 to 6.1.

  8. Lowered from7.24to7.22(-0.02)

    Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 6.3 to 6.2.

  9. Lowered from7.29to7.24(-0.05)

    Claim deductions re-checked on 22 October 2026 under the published rule (only site claims contradicted by what the certificates show), each confirmed independently from primary sources. Lab 8.8 to 8.7.

  10. Lowered from7.32to7.29(-0.03)

    Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: transparency 3.5 to 3.0.

  11. Lowered from7.54to7.32(-0.22)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. pricing 6.5 to 6.3, operating history 1.5 to 1.1, transparency 7.0 to 3.5.

  12. Raised from7.21to7.54(+0.33)

    Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: earlier judgement deductions that are not part of the published rubric were removed. Lab 8.2 to 8.8.

  13. First publishedat7.21

    lab 8.2 / shipping 6.5 / pricing 6.5 / tenure 1.5 / transparency 7.0.

Score changes for every vendor are on the score changes page. VERATIS may display its current score with the score badge, which updates automatically and has no effect on the score.

Age verification

Are you 18 or older?

Peptide Source Review covers research peptides: substances sold for laboratory and research purposes, not for human consumption. By continuing, you confirm that you are at least 18 years old and that nothing on this site is medical or legal advice.

I am not 18, leave

We use a one-time browser memory (localStorage) so you don’t see this again on this device.